RemSleep Holdings (RMSL) Research & Development (2010 - 2025)
RemSleep Holdings (RMSL) reported Research & Development of $1500.0 for Q2 2025, down 98.86% YoY from $132020.0 in Q2 2024, and down 91.28% on a QoQ basis from $17200.0 in Q1 2025.
RemSleep Holdings (RMSL) Research & Development (2010 - 2025) Analysis & Trends
RemSleep Holdings has disclosed Research & Development across 8 years of filings, most recently posting $1500.0 for Q2 2025.
- On a quarterly basis, Research & Development fell 98.86% year-over-year to $1500.0 in Q2 2025; TTM through Sep 2025 was $9350.0, a 97.66% decrease from a year earlier, with the FY2024 full-year figure at $187445.0, down 36.42% from the prior year.
- Research & Development for Q2 2025 stood at $1500.0, down from $17200.0 in the prior quarter.
- The five-year high for Research & Development was $205220.0 in Q4 2023, with the low at -$9350.0 in Q4 2024.
- A 5-year average of $55409.6 and a median of $30242.5 in 2021 frame the typical range for Research & Development.
- The sharpest annual moves came in 2021 and 2024: Research & Development soared 1632.43% in 2021, then slumped 104.56% in 2024.
- Year by year, Research & Development stood at $33703.0 in 2021, then jumped by 351.43% to $152145.0 in 2022, then jumped by 34.88% to $205220.0 in 2023, then slumped by 104.56% to -$9350.0 in 2024, then jumped by 116.04% to $1500.0 in 2025.
- Business Quant data shows RMSL's Research & Development at $1500.0 in Q2 2025, $17200.0 in Q1 2025, and -$9350.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 263.30 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 345.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 145.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 28.80 Mn |
| 10 | RemSleep Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,500.00 |
| Mar 31, 2025 | 17,200.00 |
| Dec 31, 2024 | -9,350.00 |
| Sep 30, 2024 | 40,775.00 |
| Jun 30, 2024 | 132,020.00 |
| Mar 31, 2024 | 22,188.00 |
| Dec 31, 2023 | 205,220.00 |
| Sep 30, 2023 | 13,887.00 |
| Jun 30, 2023 | 48,930.00 |
| Mar 31, 2023 | 26,782.00 |
| Dec 31, 2022 | 152,145.00 |
| Sep 30, 2022 | 121,170.00 |
| Jun 30, 2022 | 38,051.00 |
| Mar 31, 2022 | 25,667.00 |
| Dec 31, 2021 | 33,703.00 |
| Sep 30, 2021 | 16,666.00 |
| Dec 31, 2020 | 24,686.00 |
| Sep 30, 2020 | 962.00 |
| Jun 30, 2020 | 36,294.00 |
| Sep 30, 2012 | 10,250.00 |